Table 2.

Adjusted OR/HR of safety and efficacy outcome according to different stroke subtypes

Outcomes	Groups	unadjusted OR/HR (95% CI)	P value	Adjusted OR/HR (95% CI)	P value
90-day mRSa, median (IQR)	LAA-LVO	Ref		Ref
	CE-LVO	1.39(1.15–1.68)	0.006	1.05(0.79–1.41)	0.727
	SUE/SOE-LVO	0.99(0.75–1.30)	0.943	0.95(0.69–1.30)	0.746
90-day mRS 0–1a, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	0.68(0.55–0.85)	0.001	0.91(0.64–1.30)	0.603
	SUE/SOE-LVO	1.15(0.85–1.57)	0.369	1.19(0.82–1.73)	0.366
90-day mRS 0–2a, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	0.73(0.59–0.90)	0.003	1.05(0.74–1.49)	0.775
	SUE/SOE-LVO	1.13(0.83–1.54)	0.452	1.23(0.84–1.78)	0.288
90-day mRS 0–3a, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	0.79(0.63–0.97)	0.027	1.31(0.89–1.93)	0.946
	SUE/SOE-LVO	1.23(0.89–1.69)	0.215	0.99(0.70–1.40)	0.174
Successful recanalization, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	2.82(1.92–4.14)	< 0.001	1.02(0.58–1.79)	0.951
	SUE/SOE-LVO	1.26(0.67–2.39)	0.475	0.91(0.50–1.64)	0.743
Complete recanalization, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	1.32(1.05–1.66)	0.020	1.50(1.04–2.17)	0.031
	SUE/SOE-LVO	0.89(0.65–1.23)	0.474	0.96(0.65–1.41)	0.830
Death within 90 days‖, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	1.39(1.01–1.89)	0.041	1.09(0.67–1.79)	0.724
	SUE/SOE-LVO	1.36(0.87–2.12)	0.183	1.47(0.86–2.50)	0.155
SICHb, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	2.08(1.36–3.19)	0.001	1.24(0.63–2.45)	0.531
	SUE/SOE-LVO	1.08(0.53–2.20)	0.829	0.87(0.38–1.98)	0.741
PHc, n (%)	LAA-LVO	Ref		Ref
	CE-LVO	2.82(1.92–4.14)	< 0.001	1.97(1.09–3.55)	0.025
	SUE/SOE-LVO	1.26(0.67–2.39)	0.475	1.04(0.51–2.13)	0.919

LAA Large-artery atherosclerosis, CE cardioembolism, SOE stroke of other determined etiology, SUE stroke of undetermined etiology, LVO large vessel occlusion, SICH symptomatic intracranial hemorrhage, PH parenchymal hemorrhage, mRS modified rankin score

^a21 missing data

^b55 missing data

^b40 missing data